Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta-Lactamase inhibitors.

C S Conner

    Drug Intelligence & Clinical Pharmacy
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Amoxicillin/clavulanate combats bacterial resistance to beta-lactam antibiotics effectively. However, limited comparative studies and increased side effects warrant careful consideration of its therapeutic role.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Withered Yang: a review of traditional Chinese medical treatment of male infertility and erectile dysfunction.

    Journal of andrology·2001
    Same author

    Conflicting data in the literature: a true dilemma.

    Drug intelligence & clinical pharmacy·1986
    Same author

    Transdermal nitroglycerin: a reevaluation.

    Drug intelligence & clinical pharmacy·1984
    Same author

    Oral gold in arthritis.

    Drug intelligence & clinical pharmacy·1984
    Same author

    Atracurium and vecuronium: two unique neuromuscular blocking agents.

    Drug intelligence & clinical pharmacy·1984
    Same author

    Alzheimer's disease: clinical features, pathogenesis, and treatment.

    Drug intelligence & clinical pharmacy·1984
    Same journal

    Profile of prescription medication in a pediatric population.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    SI units in drug therapeutics.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Physicians' review of significant interventions by clinical pharmacists in inpatient care.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Possible interaction of ranitidine with phenytoin.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Famotidine-associated mental confusion in elderly patients.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

    Drug intelligence & clinical pharmacy·1988
    See all related articles

    Area of Science:

    • Pharmacology
    • Microbiology
    • Infectious Diseases

    Background:

    • Bacterial resistance to beta-lactam antibiotics is a significant clinical challenge.
    • Beta-lactamase inhibitors are crucial in overcoming this resistance.
    • Clavulanic acid is a key inhibitor, often combined with amoxicillin.

    Purpose of the Study:

    • To evaluate the clinical efficacy of amoxicillin/clavulanate.
    • To compare amoxicillin/clavulanate with conventional antibiotic therapies.
    • To discuss the optimal place for amoxicillin/clavulanate in treatment regimens.

    Main Methods:

    • Review of clinical studies on amoxicillin/clavulanate efficacy.
    • Analysis of comparative studies assessing superiority over standard treatments.

    Related Experiment Videos

  • Assessment of reported side effects compared to amoxicillin monotherapy.
  • Main Results:

    • Amoxicillin/clavulanate shows efficacy against many amoxicillin-resistant bacteria.
    • Few comparative studies exist, and none definitively prove superiority.
    • Side effects are reported more frequently than with amoxicillin alone.

    Conclusions:

    • Amoxicillin/clavulanate is effective against resistant organisms.
    • Further comparative research is needed to establish its superiority.
    • The balance of efficacy and side effects influences its therapeutic positioning.